{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T15:50:43Z","timestamp":1787500243713,"version":"build-2736575974"},"reference-count":69,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,12,26]],"date-time":"2022-12-26T00:00:00Z","timestamp":1672012800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,12,26]],"date-time":"2022-12-26T00:00:00Z","timestamp":1672012800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"The Velux Foundation l","award":["00025829"],"award-info":[{"award-number":["00025829"]}]},{"name":"The Velux Foundation l","award":["00025829"],"award-info":[{"award-number":["00025829"]}]},{"name":"The Velux Foundation l","award":["00025829"],"award-info":[{"award-number":["00025829"]}]},{"name":"The Velux Foundation l","award":["00025829"],"award-info":[{"award-number":["00025829"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Health Serv Res"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>First-line treatment for behavioral and psychiatric symptoms of dementia is non-pharmacological. Still, psychotropic medication is widely used, despite its limited effect and harmful side-effects. More than half of all nursing home residents with dementia receive antidepressants, even though deprescribing is safe and feasible. Interventions to promote deprescribing of antidepressants in nursing homes are few and complex. To optimize the deprescribing process through an intervention, transparency for the development of the intervention is needed. We aim to describe the steps in the development and tailoring of an intervention targeting GPs, nursing home staff, and relatives to enhance collaboration on reducing the use of antidepressants in institutionalized older persons with dementia in Denmark.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Method<\/jats:title>\n                    <jats:p>A step-wise process guided by the core elements in the Medical Research Council constituted the tailoring process. Five steps were included; 1) a literature search, 2) interviews with stakeholders, 3) drafting the intervention prototype, 4) professionals\u2019 assessment of the intervention, and 5) refinement of the intervention. The steps were conducted from June 2020 to June 2022.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Based on the literature search, interviews with stakeholders, and professionals\u2019 assessment of the intervention, four main themes were identified; 1) focusing on antidepressants, 2) importance of professional qualifications, 3) collaboration and communication, and 4) patient and relative involvement. They guided intervention development and refinement of the final intervention, which included 1) a case-based training course and 2) a dialog tool including a symptom assessment scale to be used in a structured consultation at the nursing home.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This study presents a detailed account of the tailoring process for a complex intervention to optimize deprescribing of antidepressants for older persons with dementia at nursing homes. By presenting a thorough development process, we expect to achieve increased adherence to the intervention which is currently being tested in an ongoing cluster randomized controlled trial. The transparency of the process will also increase the future development of other similar complex interventions.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12913-022-08961-9","type":"journal-article","created":{"date-parts":[[2022,12,26]],"date-time":"2022-12-26T01:02:54Z","timestamp":1672016574000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Tailoring a complex intervention to reduce antidepressants in institutionalized older persons with dementia"],"prefix":"10.1186","volume":"22","author":[{"given":"Pernille","family":"H\u00f8lmkj\u00e6r","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte","family":"Vermehren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Holm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maarten Pieter","family":"Rozing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirsten","family":"H\u00f8j","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gritt","family":"Overbeck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,12,26]]},"reference":[{"key":"8961_CR1","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/B978-0-444-64012-3.00002-2","volume":"165","author":"WJ Deardorff","year":"2019","unstructured":"Deardorff WJ, Grossberg GT. Behavioral and psychological symptoms in Alzheimer\u2019s dementia and vascular dementia. Handb Clin Neurol. 2019;165:5\u201332.","journal-title":"Handb Clin Neurol"},{"issue":"1","key":"8961_CR2","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1017\/S1041610213001609","volume":"26","author":"G Selbaek","year":"2014","unstructured":"Selbaek G, Engedal K, Benth J, Bergh S. The course of neuropsychiatric symptoms in nursing-home patients with dementia over a 53-month follow-up period. Int Psychogeriatr. 2014;26(1):81\u201391.","journal-title":"Int Psychogeriatr"},{"issue":"8","key":"8961_CR3","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1007\/s11920-019-1049-5","volume":"21","author":"LJ Bessey","year":"2019","unstructured":"Bessey LJ, Walaszek A. Management of behavioral and psychological symptoms of dementia. Curr Psychiatry Rep. 2019;21(8):66.","journal-title":"Curr Psychiatry Rep"},{"issue":"3","key":"8961_CR4","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.jamda.2005.12.024","volume":"7","author":"KN Franco","year":"2006","unstructured":"Franco KN, Messinger-Rapport B. Pharmacological treatment of neuropsychiatric symptoms of dementia: a review of the evidence. J Am Med Dir Assoc. 2006;7(3):201\u20132.","journal-title":"J Am Med Dir Assoc"},{"issue":"4","key":"8961_CR5","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1111\/jgs.12730","volume":"62","author":"HC Kales","year":"2014","unstructured":"Kales HC, Gitlin LN, Lyketsos CG. Management of neuropsychiatric symptoms of dementia in clinical settings: recommendations from a multidisciplinary expert panel. J Am Geriatr Soc. 2014;62(4):762\u20139.","journal-title":"J Am Geriatr Soc"},{"key":"8961_CR6","doi-asserted-by":"publisher","first-page":"652254","DOI":"10.3389\/fpsyt.2021.652254","volume":"12","author":"S Macfarlane","year":"2021","unstructured":"Macfarlane S, Atee M, Morris T, Whiting D, Healy M, Alford M, et al. Evaluating the clinical impact of national dementia behaviour support programs on neuropsychiatric outcomes in Australia. Front Psychiatry. 2021;12:652254.","journal-title":"Front Psychiatry"},{"issue":"3","key":"8961_CR7","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1017\/S1041610217002344","volume":"30","author":"SM Dyer","year":"2018","unstructured":"Dyer SM, Harrison SL, Laver K, Whitehead C, Crotty M. An overview of systematic reviews of pharmacological and non-pharmacological interventions for the treatment of behavioral and psychological symptoms of dementia. Int Psychogeriatr. 2018;30(3):295\u2013309.","journal-title":"Int Psychogeriatr"},{"issue":"3","key":"8961_CR8","doi-asserted-by":"publisher","first-page":"e190828","DOI":"10.1001\/jamanetworkopen.2019.0828","volume":"2","author":"I Yunusa","year":"2019","unstructured":"Yunusa I, Alsumali A, Garba AE, Regestein QR, Eguale T. Assessment of reported comparative effectiveness and safety of atypical antipsychotics in the treatment of behavioral and psychological symptoms of dementia: a network meta-analysis. JAMA Netw Open. 2019;2(3):e190828.","journal-title":"JAMA Netw Open"},{"issue":"5","key":"8961_CR9","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1093\/ageing\/afaa029","volume":"49","author":"C Lundby","year":"2020","unstructured":"Lundby C, Jensen J, Larsen SP, Hoffmann H, Potteg\u00e5rd A, Reilev M. Use of medication among nursing home residents: a Danish drug utilisation study. Age Ageing. 2020;49(5):814\u201320.","journal-title":"Age Ageing"},{"key":"8961_CR10","doi-asserted-by":"crossref","unstructured":"Gourdon M, Petit L, Delpierre S, Sebbagh-Eczet M, Estrada J, Marquis C, et al. Overuse of antidepressants in older outpatients with Alzheimer's disease and associated disorders: an observational study. Geriatr Psychol Neuropsychiatr Vieil. 2021.","DOI":"10.1684\/pnv.2020.0850"},{"issue":"7","key":"8961_CR11","first-page":"E411","volume":"183","author":"KF Huybrechts","year":"2011","unstructured":"Huybrechts KF, Rothman KJ, Silliman RA, Brookhart MA, Schneeweiss S. Risk of death and hospital admission for major medical events after initiation of psychotropic medications in older adults admitted to nursing homes. CMAJ. 2011;183(7):E411\u20139.","journal-title":"CMAJ"},{"issue":"28","key":"8961_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3310\/hta15280","volume":"15","author":"CA Coupland","year":"2011","unstructured":"Coupland CA, Dhiman P, Barton G, Morriss R, Arthur A, Sach T, et al. A study of the safety and harms of antidepressant drugs for older people: a cohort study using a large primary care database. Health Technol Assess. 2011;15(28):1\u2013202, iii\u2212iv.","journal-title":"Health Technol Assess."},{"key":"8961_CR13","unstructured":"retningslinjer S-Nk. Forebyggelse og behandling af adf\u00e6rdsm\u00e6ssige og psykiske symptomer hos personer med demens. . 2019."},{"key":"8961_CR14","unstructured":"retningslinjer S-Nk. Demens og medicin. 2018."},{"issue":"2","key":"8961_CR15","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.jamda.2019.08.027","volume":"21","author":"B Cossette","year":"2020","unstructured":"Cossette B, Bruneau MA, Couturier Y, Gilbert S, Boyer D, Ricard J, et al. Optimizing Practices, Use, Care and Services-Antipsychotics (OPUS-AP) in long-term care centers in Qu\u00e9bec, Canada: a strategy for best practices. J Am Med Dir Assoc. 2020;21(2):212\u20139.","journal-title":"J Am Med Dir Assoc"},{"issue":"1","key":"8961_CR16","first-page":"17","volume":"64","author":"LM Bjerre","year":"2018","unstructured":"Bjerre LM, Farrell B, Hogel M, Graham L, Lemay G, McCarthy L, et al. Deprescribing antipsychotics for behavioural and psychological symptoms of dementia and insomnia: evidence-based clinical practice guideline. Can Fam Physician. 2018;64(1):17\u201327.","journal-title":"Can Fam Physician"},{"key":"8961_CR17","first-page":"Cd007726","volume":"3","author":"T Declercq","year":"2013","unstructured":"Declercq T, Petrovic M, Azermai M, Vander Stichele R, De Sutter AI, van Driel ML, et al. Withdrawal versus continuation of chronic antipsychotic drugs for behavioural and psychological symptoms in older people with dementia. Cochrane Database Syst Rev. 2013;3:Cd007726.","journal-title":"Cochrane Database Syst Rev."},{"key":"8961_CR18","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.ejim.2016.12.021","volume":"38","author":"E Reeve","year":"2017","unstructured":"Reeve E, Thompson W, Farrell B. Deprescribing: A narrative review of the evidence and practical recommendations for recognizing opportunities and taking action. Eur J Intern Med. 2017;38:3\u201311.","journal-title":"Eur J Intern Med"},{"issue":"3","key":"8961_CR19","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1111\/bcp.12975","volume":"82","author":"AT Page","year":"2016","unstructured":"Page AT, Clifford RM, Potter K, Schwartz D, Etherton-Beer CD. The feasibility and effect of deprescribing in older adults on mortality and health: a systematic review and meta-analysis. Br J Clin Pharmacol. 2016;82(3):583\u2013623.","journal-title":"Br J Clin Pharmacol"},{"key":"8961_CR20","doi-asserted-by":"crossref","unstructured":"American Geriatrics Society 2019 Updated AGS Beers Criteria\u00ae for Potentially Inappropriate Medication Use in Older Adults. J Am Geriatr Soc. 2019;67(4):674\u201394.","DOI":"10.1111\/jgs.15767"},{"issue":"2","key":"8961_CR21","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1093\/ageing\/afu145","volume":"44","author":"D O'Mahony","year":"2015","unstructured":"O\u2019Mahony D, O\u2019Sullivan D, Byrne S, O\u2019Connor MN, Ryan C, Gallagher P. STOPP\/START criteria for potentially inappropriate prescribing in older people: version 2. Age Ageing. 2015;44(2):213\u20138.","journal-title":"Age Ageing"},{"key":"8961_CR22","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/1471-2318-11-16","volume":"11","author":"L Forsetlund","year":"2011","unstructured":"Forsetlund L, Eike MC, Gjerberg E, Vist GE. Effect of interventions to reduce potentially inappropriate use of drugs in nursing homes: a systematic review of randomised controlled trials. BMC Geriatr. 2011;11:16.","journal-title":"BMC Geriatr"},{"issue":"10","key":"8961_CR23","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1016\/j.jamda.2014.06.012","volume":"15","author":"J Thompson Coon","year":"2014","unstructured":"Thompson Coon J, Abbott R, Rogers M, Whear R, Pearson S, Lang I, et al. Interventions to reduce inappropriate prescribing of antipsychotic medications in people with dementia resident in care homes: a systematic review. J Am Med Dir Assoc. 2014;15(10):706\u201318.","journal-title":"J Am Med Dir Assoc"},{"issue":"11","key":"8961_CR24","doi-asserted-by":"publisher","first-page":"1572","DOI":"10.1002\/gps.5167","volume":"34","author":"L Aerts","year":"2019","unstructured":"Aerts L, Cations M, Harrison F, Jessop T, Shell A, Chenoweth L, et al. Why deprescribing antipsychotics in older people with dementia in long-term care is not always successful: insights from the HALT study. Int J Geriatr Psychiatry. 2019;34(11):1572\u201381.","journal-title":"Int J Geriatr Psychiatry"},{"issue":"2","key":"8961_CR25","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1111\/bcp.14947","volume":"88","author":"I Bu\u017ean\u010di\u0107","year":"2022","unstructured":"Bu\u017ean\u010di\u0107 I, Kummer I, Dr\u017eai\u0107 M, Ortner HM. Community-based pharmacists\u2019 role in deprescribing: a systematic review. Br J Clin Pharmacol. 2022;88(2):452\u201363.","journal-title":"Br J Clin Pharmacol"},{"issue":"2","key":"8961_CR26","doi-asserted-by":"publisher","first-page":"57","DOI":"10.3390\/pharmacy8020057","volume":"8","author":"DA Dalin","year":"2020","unstructured":"Dalin DA, Vermehren C, Jensen AK, Unkerskov J, Andersen JT. Systematic medication review in general practice by an interdisciplinary team: a thorough but laborious method to address polypharmacy among elderly patients. Pharmacy (Basel). 2020;8(2):57.","journal-title":"Pharmacy (Basel)."},{"issue":"4","key":"8961_CR27","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1016\/j.sapharm.2020.06.010","volume":"17","author":"M Sawan","year":"2021","unstructured":"Sawan M, O\u2019Donnell LK, Reeve E, Gnjidic D, Chen TF, Kelly PJ, et al. The utility of a computerised clinical decision support system intervention in home medicines review: a mixed-methods process evaluation. Res Social Adm Pharm. 2021;17(4):715\u201322.","journal-title":"Res Social Adm Pharm"},{"issue":"2","key":"8961_CR28","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1007\/s40266-018-0623-6","volume":"36","author":"SL Harrison","year":"2019","unstructured":"Harrison SL, Cations M, Jessop T, Hilmer SN, Sawan M, Brodaty H. Approaches to deprescribing psychotropic medications for changed behaviours in long-term care residents living with dementia. Drugs Aging. 2019;36(2):125\u201336.","journal-title":"Drugs Aging"},{"issue":"10","key":"8961_CR29","doi-asserted-by":"publisher","first-page":"e0140203","DOI":"10.1371\/journal.pone.0140203","volume":"10","author":"S Jordan","year":"2015","unstructured":"Jordan S, Gabe-Walters ME, Watkins A, Humphreys I, Newson L, Snelgrove S, et al. Nurse-led medicines\u2019 monitoring for patients with dementia in care homes: a pragmatic cohort stepped wedge cluster randomised trial. PLoS ONE. 2015;10(10):e0140203.","journal-title":"PLoS ONE"},{"issue":"8","key":"8961_CR30","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1007\/s40266-021-00875-1","volume":"38","author":"AE Moth","year":"2021","unstructured":"Moth AE, H\u00f8lmkj\u00e6r P, Holm A, Rozing MP, Overbeck G. What makes deprescription of psychotropic drugs in nursing home residents with dementia so challenging? a qualitative systematic review of barriers and facilitators. Drugs Aging. 2021;38(8):671\u201385.","journal-title":"Drugs Aging."},{"issue":"7","key":"8961_CR31","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1016\/j.jamda.2018.05.002","volume":"19","author":"H Brodaty","year":"2018","unstructured":"Brodaty H, Aerts L, Harrison F, Jessop T, Cations M, Chenoweth L, et al. Antipsychotic deprescription for older adults in long-term care: the HALT study. J Am Med Dir Assoc. 2018;19(7):592-600.e7.","journal-title":"J Am Med Dir Assoc"},{"issue":"1","key":"8961_CR32","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1186\/s12877-021-02220-y","volume":"21","author":"D Cateau","year":"2021","unstructured":"Cateau D, Ballabeni P, Niquille A. Effects of an interprofessional Quality Circle-Deprescribing Module (QC-DeMo) in Swiss nursing homes: a randomised controlled trial. BMC Geriatr. 2021;21(1):289.","journal-title":"BMC Geriatr"},{"issue":"1","key":"8961_CR33","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1186\/s12912-022-00963-6","volume":"21","author":"C Richter","year":"2022","unstructured":"Richter C, Fleischer S, Langner H, Meyer G, Balzer K, K\u00f6pke S, et al. Factors influencing the implementation of person-centred care in nursing homes by practice development champions: a qualitative process evaluation of a cluster-randomised controlled trial (EPCentCare) using Normalization Process Theory. BMC Nurs. 2022;21(1):182.","journal-title":"BMC Nurs"},{"issue":"1","key":"8961_CR34","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1186\/s12913-020-05282-7","volume":"20","author":"DE Patton","year":"2020","unstructured":"Patton DE, Ryan C, Hughes CM. Development of a complex community pharmacy intervention package using theory-based behaviour change techniques to improve older adults\u2019 medication adherence. BMC Health Serv Res. 2020;20(1):418.","journal-title":"BMC Health Serv Res"},{"issue":"4","key":"8961_CR35","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1111\/bcp.12386","volume":"78","author":"E Reeve","year":"2014","unstructured":"Reeve E, Shakib S, Hendrix I, Roberts MS, Wiese MD. Review of deprescribing processes and development of an evidence-based, patient-centred deprescribing process. Br J Clin Pharmacol. 2014;78(4):738\u201347.","journal-title":"Br J Clin Pharmacol"},{"issue":"12","key":"8961_CR36","doi-asserted-by":"publisher","first-page":"2716","DOI":"10.1111\/bcp.13742","volume":"84","author":"CR Hansen","year":"2018","unstructured":"Hansen CR, O\u2019Mahony D, Kearney PM, Sahm LJ, Cullinan S, Huibers CJA, et al. Identification of behaviour change techniques in deprescribing interventions: a systematic review and meta-analysis. Br J Clin Pharmacol. 2018;84(12):2716\u201328.","journal-title":"Br J Clin Pharmacol"},{"key":"8961_CR37","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.a1655","volume":"337","author":"P Craig","year":"2008","unstructured":"Craig P, Dieppe P, Macintyre S, Michie S, Nazareth I, Petticrew M. Developing and evaluating complex interventions: the new Medical Research Council guidance. BMJ. 2008;337: a1655.","journal-title":"BMJ"},{"key":"8961_CR38","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n2061","volume":"374","author":"K Skivington","year":"2021","unstructured":"Skivington K, Matthews L, Simpson SA, Craig P, Baird J, Blazeby JM, et al. A new framework for developing and evaluating complex interventions: update of Medical Research Council guidance. BMJ. 2021;374: n2061.","journal-title":"BMJ"},{"issue":"9391","key":"8961_CR39","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1016\/S0140-6736(03)14546-1","volume":"362","author":"R Grol","year":"2003","unstructured":"Grol R, Grimshaw J. From best evidence to best practice: effective implementation of change in patients\u2019 care. Lancet (London, England). 2003;362(9391):1225\u201330.","journal-title":"Lancet (London, England)"},{"issue":"2","key":"8961_CR40","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.jclinepi.2004.09.002","volume":"58","author":"M Eccles","year":"2005","unstructured":"Eccles M, Grimshaw J, Walker A, Johnston M, Pitts N. Changing the behavior of healthcare professionals: the use of theory in promoting the uptake of research findings. J Clin Epidemiol. 2005;58(2):107\u201312.","journal-title":"J Clin Epidemiol"},{"issue":"6","key":"8961_CR41","doi-asserted-by":"publisher","first-page":"iii-iv, 1","DOI":"10.3310\/hta8060","volume":"8","author":"JM Grimshaw","year":"2004","unstructured":"Grimshaw JM, Thomas RE, MacLennan G, Fraser C, Ramsay CR, Vale L, et al. Effectiveness and efficiency of guideline dissemination and implementation strategies. Health Technol Assess. 2004;8(6):iii\u2013iv, 1\u201372.","journal-title":"Health Technol Assess"},{"key":"8961_CR42","unstructured":"Pernille H, Anne H, Gritt O, Maarten Pieter R. A Cluster-randomized Trial of a Complex Intervention to Encourage Deprescribing Antidepressants in Nursing Home Residents With Dementia: a Study Protocol. Trials. 2022."},{"key":"8961_CR43","unstructured":"S-o \u00c6. Plejehjemsoversigten. 2021."},{"key":"8961_CR44","unstructured":"\u00e6ldreministeriet S-o. National unders\u00f8gelse af forholdende p\u00e5 plejecentre. 2016."},{"key":"8961_CR45","unstructured":"(VIVE) Dnf-oafv. Normeringer p\u00e5 danske plejecentre. 2019."},{"issue":"6","key":"8961_CR46","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1093\/intqhc\/mzm042","volume":"19","author":"A Tong","year":"2007","unstructured":"Tong A, Sainsbury P, Craig J. Consolidated criteria for reporting qualitative research (COREQ): a 32-item checklist for interviews and focus groups. Int J Qual Health Care. 2007;19(6):349\u201357.","journal-title":"Int J Qual Health Care"},{"key":"8961_CR47","doi-asserted-by":"publisher","first-page":"g1687","DOI":"10.1136\/bmj.g1687","volume":"348","author":"TC Hoffmann","year":"2014","unstructured":"Hoffmann TC, Glasziou PP, Boutron I, Milne R, Perera R, Moher D, et al. Better reporting of interventions: template for intervention description and replication (TIDieR) checklist and guide. BMJ. 2014;348:g1687.","journal-title":"BMJ"},{"issue":"8","key":"8961_CR48","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1007\/s40266-021-00875-1","volume":"38","author":"AE Moth","year":"2021","unstructured":"Moth AE, H\u00f8lmkj\u00e6r P, Holm A, Rozing MP, Overbeck G. What makes deprescription of psychotropic drugs in nursing home residents with dementia so challenging? a qualitative systematic review of barriers and facilitators. Drugs Aging. 2021;38(8):671\u201385.","journal-title":"Drugs Aging"},{"key":"8961_CR49","volume-title":"InterViews: An Introduction to Qualitative Research Interviewing","author":"S Kvale","year":"1996","unstructured":"Kvale S. InterViews: An Introduction to Qualitative Research Interviewing. Thousand Oaks, CA: Sage Publications; 1996."},{"issue":"2","key":"8961_CR50","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1191\/1478088706qp063oa","volume":"3","author":"V Braun","year":"2006","unstructured":"Braun V, Clarke V. Using thematic analysis in psychology. Qual Res Psychol. 2006;3(2):77\u2013101.","journal-title":"Qual Res Psychol"},{"issue":"12","key":"8961_CR51","doi-asserted-by":"publisher","first-page":"2308","DOI":"10.1212\/WNL.44.12.2308","volume":"44","author":"JL Cummings","year":"1994","unstructured":"Cummings JL, Mega M, Gray K, Rosenberg-Thompson S, Carusi DA, Gornbein J. The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia. Neurology. 1994;44(12):2308\u201314.","journal-title":"Neurology"},{"issue":"3","key":"8961_CR52","first-page":"318","volume":"10","author":"J Nystrup","year":"2010","unstructured":"Nystrup J, Larsen JH, Ris\u00f8r O. Developing communication skills for the general practice consultation process. Sultan Qaboos Univ Med J. 2010;10(3):318\u201325.","journal-title":"Sultan Qaboos Univ Med J"},{"issue":"2","key":"8961_CR53","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1111\/j.1365-2923.1996.tb00724.x","volume":"30","author":"SM Kurtz","year":"1996","unstructured":"Kurtz SM, Silverman JD. The Calgary-Cambridge Referenced Observation Guides: an aid to defining the curriculum and organizing the teaching in communication training programmes. Med Educ. 1996;30(2):83\u20139.","journal-title":"Med Educ"},{"issue":"5","key":"8961_CR54","doi-asserted-by":"publisher","first-page":"228","DOI":"10.4140\/TCP.n.2021.228","volume":"36","author":"D Mangin","year":"2021","unstructured":"Mangin D, Siu HYH. Deprescribing antidepressants in older people - breaking up can be hard to do. Sr Care Pharm. 2021;36(5):228\u201337.","journal-title":"Sr Care Pharm"},{"issue":"1","key":"8961_CR55","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1016\/j.mayocp.2020.06.012","volume":"96","author":"RW Hoel","year":"2021","unstructured":"Hoel RW, Giddings Connolly RM, Takahashi PY. Polypharmacy management in older patients. Mayo Clin Proc. 2021;96(1):242\u201356.","journal-title":"Mayo Clin Proc"},{"issue":"1","key":"8961_CR56","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1186\/s12877-020-01870-8","volume":"20","author":"S Zechmann","year":"2020","unstructured":"Zechmann S, Senn O, Valeri F, Essig S, Merlo C, Rosemann T, et al. Effect of a patient-centred deprescribing procedure in older multimorbid patients in Swiss primary care - a cluster-randomised clinical trial. BMC Geriatr. 2020;20(1):471.","journal-title":"BMC Geriatr"},{"key":"8961_CR57","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1186\/1472-6963-7-148","volume":"7","author":"C May","year":"2007","unstructured":"May C, Finch T, Mair F, Ballini L, Dowrick C, Eccles M, et al. Understanding the implementation of complex interventions in health care: the normalization process model. BMC Health Serv Res. 2007;7:148.","journal-title":"BMC Health Serv Res"},{"key":"8961_CR58","doi-asserted-by":"publisher","first-page":"23","DOI":"10.12688\/hrbopenres.13228.1","volume":"4","author":"KA Walsh","year":"2021","unstructured":"Walsh KA, Byrne S, McSharry J, Browne J, Irving K, Hurley E, et al. Developing a complex intervention targeting antipsychotic prescribing to nursing home residents with dementia. HRB Open Res. 2021;4:23.","journal-title":"HRB Open Res"},{"issue":"6","key":"8961_CR59","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1016\/j.sapharm.2018.08.009","volume":"15","author":"KR Weir","year":"2019","unstructured":"Weir KR, Bonner C, McCaffery K, Naganathan V, Carter SM, Rigby D, et al. Pharmacists and patients sharing decisions about medicines: development and feasibility of a conversation guide. Res Social Adm Pharm. 2019;15(6):682\u201390.","journal-title":"Res Social Adm Pharm"},{"issue":"3","key":"8961_CR60","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1111\/jebm.12359","volume":"12","author":"C Stewart","year":"2019","unstructured":"Stewart C, Gallacher K, Nakham A, Cruickshank M, Newlands R, Bond C, et al. Barriers and facilitators to reducing anticholinergic burden from the perspectives of patients, their carers, and healthcare professionals: a protocol for qualitative evidence synthesis. J Evid Based Med. 2019;12(3):227\u201331.","journal-title":"J Evid Based Med"},{"issue":"1","key":"8961_CR61","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1186\/s13063-020-04482-0","volume":"21","author":"EA Bayliss","year":"2020","unstructured":"Bayliss EA, Shetterly SM, Drace ML, Norton J, Green AR, Reeve E, et al. The OPTIMIZE patient- and family-centered, primary care-based deprescribing intervention for older adults with dementia or mild cognitive impairment and multiple chronic conditions: study protocol for a pragmatic cluster randomized controlled trial. Trials. 2020;21(1):542.","journal-title":"Trials"},{"key":"8961_CR62","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1007\/978-3-319-08939-3_8","volume":"821","author":"C Plakiotis","year":"2015","unstructured":"Plakiotis C, Bell JS, Jeon YH, Pond D, O\u2019Connor DW. Deprescribing psychotropic medications in aged care facilities: the potential role of family members. Adv Exp Med Biol. 2015;821:29\u201343.","journal-title":"Adv Exp Med Biol"},{"issue":"1","key":"8961_CR63","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1080\/13814788.2022.2038131","volume":"28","author":"E Van Leeuwen","year":"2022","unstructured":"Van Leeuwen E, Anthierens S, van Driel ML, De Sutter AIM, van den Branden E, Christiaens T. General practitioners\u2019 perspectives on discontinuation of long-term antidepressants in nursing homes. Eur J Gen Pract. 2022;28(1):23\u201331.","journal-title":"Eur J Gen Pract"},{"issue":"4","key":"8961_CR64","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1080\/02813432.2021.2006487","volume":"39","author":"VL Ellen","year":"2021","unstructured":"Ellen VL, Anthierens S, van Driel ML, Sutter A, Branden EVD, Christiaens T. \u201cNever change a winning team\u201d: GPs\u2019 perspectives on discontinuation of long-term antidepressants. Scand J Prim Health Care. 2021;39(4):533\u201342.","journal-title":"Scand J Prim Health Care"},{"issue":"4","key":"8961_CR65","doi-asserted-by":"publisher","first-page":"e046054","DOI":"10.1136\/bmjopen-2020-046054","volume":"11","author":"D Kelly","year":"2021","unstructured":"Kelly D, Graffi J, Noonan M, Green P, McFarland J, Hayes P, et al. Exploration of GP perspectives on deprescribing antidepressants: a qualitative study. BMJ Open. 2021;11(4):e046054.","journal-title":"BMJ Open"},{"issue":"6","key":"8961_CR66","doi-asserted-by":"publisher","first-page":"1764","DOI":"10.1111\/jgs.17730","volume":"70","author":"ME Growdon","year":"2022","unstructured":"Growdon ME, Espejo E, Jing B, Boscardin WJ, Zullo AR, Yaffe K, et al. Attitudes toward deprescribing among older adults with dementia in the United States. J Am Geriatr Soc. 2022;70(6):1764\u201373.","journal-title":"J Am Geriatr Soc."},{"key":"8961_CR67","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1186\/1472-6963-12-241","volume":"12","author":"KL Smebye","year":"2012","unstructured":"Smebye KL, Kirkevold M, Engedal K. How do persons with dementia participate in decision making related to health and daily care? a multi-case study. BMC Health Serv Res. 2012;12:241.","journal-title":"BMC Health Serv Res"},{"key":"8961_CR68","unstructured":"Health DMo. Danish Healthcare Act. 2016."},{"key":"8961_CR69","volume-title":"Danish Act on Clinical Trials of Medicinal Products","author":"Agency DM","year":"2016","unstructured":"Agency DM. Danish Act on Clinical Trials of Medicinal Products. 2016."}],"container-title":["BMC Health Services Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12913-022-08961-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12913-022-08961-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12913-022-08961-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,26]],"date-time":"2022-12-26T02:03:32Z","timestamp":1672020212000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmchealthservres.biomedcentral.com\/articles\/10.1186\/s12913-022-08961-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,26]]},"references-count":69,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["8961"],"URL":"https:\/\/doi.org\/10.1186\/s12913-022-08961-9","relation":{},"ISSN":["1472-6963"],"issn-type":[{"value":"1472-6963","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,26]]},"assertion":[{"value":"26 April 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 December 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 December 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was conducted in compliance with the Helsinki Declaration in its latest form, good clinical practice guidelines, and followed the rules for informed consent. According to Danish legislation and defined in \u201cDanish Act on Research Ethics Review of Health Research Projects, Sect. 2\u201d this trial constitutes a qualitative improvement study and does not directly interfere with patients concerning novel treatments, which does not require external monitoring nor ethical approval according to the Committee Act, Sect.\u00a01, subsection 4. The Regional Ethical Committee was informed about the trial and waivered ethical approval according to the mentioned legislation [\n                      \n                      ,\n                      \n                      ] (Journal no: H-20084023).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1582"}}